Dilaudid Injection, Solution
Product Images NDC 76045-009

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Dilaudid (NDC 76045-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dil0a 0001 01

FDA Label Image

Dil0a 0001 02

FDA Label Image

Dil0a 0001 03

FDA Label Image

Dil0a 0001 04

FDA Label Image

Dil0a 0001 05

FDA Label Image

Dil0a 0001 06

FDA Label Image

Dil0a 0001 07

This is a description for Dilaudid® [HYDROmorphone HO n,s] Injection. The package seems to contain 0.5mL of the drug manufactured by Frosenis Kabi. The code N(01)00376045009365 may refer to the product's identification.*

FDA Label Image

Dil0a 0001 08

This text appears to be a label of a medication, specifically Dilaudid® T, which is supplied as an injection containing 0.5mg hydrochloride (HYDROmorphone HCl). It advises to protect the medicine from light and to store it at controlled room temperature, as per the USP guidelines. The label also instructs not to use the injection for IV push, dilute it or place the syringe on any surface. It provides the NDC code for use in the subcutaneous, IM or slow IV administration. The packaging comes with a twist cap that should be opened before use.*

FDA Label Image

Dil0a 0001 09

This is a description of Dilaudid® (HYDROmorphone HCI) Injection, which is used for subcutaneous, intramuscular, or slow intravenous use. It is available in 0.5mg per 0.5ml single-dose pre-filled syringes. The drug should not be diluted for IV push, and the syringe should not be placed on a Sterile Field. The unused portion of the drug should be discarded. The recommended storage temperature is 20-25°C. Dosage should be determined based on the package instructions.*

FDA Label Image

Dil0a 0001 10

This is a prescription medicine in a 1mL single-dose for subcutaneous, intramuscular or slow intravenous use. The manufacturer is Fresenius Kabi and the medicine contains Hydrochloride (HCI). The concentration is 0.2 and the product code is 403609. The medicine is an injection USP with immediate release (IR).*

FDA Label Image

Dil0a 0001 11

This is a description of a single-dose prefilled syringe of Dilaudid (Hydromorphone HCl) for subcutaneous, IM, or slow IV use. It is important to store this syringe between 68°F to 77°F, and protect from light. The syringe should not be placed on a sterile field and should not be diluted for IV push. The prescription drug is only available with a prescription (Rx only) and has an NDC code of 76045-121-01. The cap can be opened by twisting it.*

FDA Label Image

Dil0a 0001 12

This text seems to be a description of a medication named Dilaudid, which is an injection used for subcutaneous, intramuscular, or slow intravenous use. The medication contains 2mg of hydromorphone hydrochloride, and its dosage is specified in the package. Instructions are provided to not dilute the medication for IV push or place the syringe on a sterile field. The package contains 10 x 1 mL single-dose prefilled syringes. There is also a marking for "NO INK OR AQ" in the medication area.*

FDA Label Image

Dil0a 0001 13

The text appears to be a label for a medication manufactured by Fresenius Kabi. It is a single-dose medication intended for SC, IM, or slow IV use, and is available in 0.5mL and 1mL doses. The label also contains a prescription requirement.*

FDA Label Image

Dil0a 0001 14

This is a description of a medication called Dila“did® in a 1 mL single-dose prefilled syringe. It should be stored at 20° to 25°C (68° to 77°F) and protected from light. It is recommended for subcutaneous, IM, or slow IV use and should not be diluted for IV push. The syringe should not be placed on a sterile field. The medication contains HYDROmOrphOne Hcl and is only available with a prescription (Rx only). The product is manufactured by Fresenius Kabi and has NDC 76045-009-01.*

FDA Label Image

Dil0a 0001 15

This is a medication label for hydromorphone hydrochloride, which is used for subcutaneous, intramuscular, or slow intravenous use. It contains one milligram of hydromorphone hydrochloride and other active and inactive ingredients. The label warns not to dilute or push the medication and not to place the syringe on any sterile field. The medication is available in prefilled syringes of 0.1 mL or 1 mL, and unused portions must be discarded. It also includes the medication's NDC code and instructions to store it at a controlled room temperature.*

FDA Label Image

Dil0a 0001 16

FDA Label Image

Dil0a 0001 17

This is a description of a single-dose prefilled syringe with a capacity of 1 mL. The recommended storage temperature for the syringe is between 20°C and 25°C (68°F and 77°F), with controlled room temperature being specified in the USP guidelines. Protection from light is required, and the syringe should not be diluted for IV push or placed on a sterile field. This syringe is intended for subcutaneous, intramuscular, or slow IV use and has an NDC of 76045-010-01. The syringe can be opened by twisting the cap. The text also includes a number (403431).*

FDA Label Image

Dil0a 0001 18

This text provides information about a medication containing 2mg of hydromorphone hydrochloride and other inactive ingredients used for subcutaneous, intramuscular, or slow intravenous administration. It also includes directions for use, storage, and precautions. The text includes several references to an NDC number (76045-010-11) and mentions pre-filled syringes available in 1 ml single-dose or 10x1 ml pre-filled formats.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.